Sign in

CIK 0001070494

  • Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
061376651
Phone
+1 858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Open-market sale EVP and CCO sold 1,247 shares at $42.56 ($53,072)
  2. 4 Open-market sale President sold 1,297 shares at $42.56 ($55,200)
  3. 4 Open-market sale CEO sold 2,960 shares at $42.56 ($125,978)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 3/A Insider 3/A
  7. 4 Open-market sale EVP and CCO sold 27,250 shares at an average $56.25 ($1,532,786)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Director acquired 12,236 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale President sold 82,295 shares at an average $50.03 ($4,117,244)
  15. 4 Open-market sale CEO sold 200,000 shares at an average $46.02 ($9,204,692)
  16. 4 Open-market sale Director sold 26,250 shares at $51.13 ($1,342,178)
  17. 4 Open-market sale EVP & General Counsel sold 1,072 shares at $49.22 ($52,764)
  18. 4 Open-market sale EVP and CCO sold 1,501 shares at $49.21 ($73,864)
  19. 4 Open-market sale CEO sold 6,770 shares at $49.21 ($333,152)
  20. 4 Open-market sale EVP and CFO sold 11,050 shares at an average $50.59 ($559,034)

Page 12 of 35 · 686 filings